Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
42.84
-0.29 (-0.67%)
At close: Aug 5, 2025, 4:00 PM
42.80
-0.04 (-0.09%)
After-hours: Aug 5, 2025, 6:44 PM EDT
The Duckhorn Portfolio Market Cap
Celcuity has a market cap or net worth of $1.75 billion as of August 5, 2025. Its market cap has increased by 181.79% in one year.
Market Cap
1.75B
Enterprise Value
1.64B
1-Year Change
181.79%
Ranking
Category
Stock Price
$42.84
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $138.93M to $1.75B, an increase of 1,156.60%. That is a compound annual growth rate of 37.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 1.76B | 261.63% |
| Dec 31, 2024 | 486.03M | 32.18% |
| Dec 29, 2023 | 367.71M | 21.13% |
| Dec 30, 2022 | 303.56M | 54.26% |
| Dec 31, 2021 | 196.78M | 108.63% |
| Dec 31, 2020 | 94.32M | -13.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |